Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Tanvex BioPharma

Tracked across 1 events · 6 articles · First seen May 12, 2026 · Last active May 13, 2026

Sentiment
50
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
4 50
Business
Bora Pharmaceuticals announced on May 12, 2026, that its Board of Directors has approved the acquisition of the GMP manufacturing operations, including the CDMO business, of MacroGenics, Inc. for a total consideration of US$122.5 million,…
Impact: Tanvex BioPharma operates Bora Pharmaceuticals' biologics CDMO franchise under the 'Bora Biologics' brand, and will cooperate with Bora Pharmaceuticals to leverage the acquired Rockville Site.
May 12, 2026 · 6 articles
NEWSDESK
Track Tanvex BioPharma live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.